Search Results 321-330 of 17359 for GLP-1 secretion
Prior exposure to exenatide or other GLP-1R agonists. Prior exposure to NLY01. Participating Mayo Clinic locations. Study statuses change often. Please ...
... 1 (NT1) or Narcolepsy Type 2 (NT2) when taking ALKS 2680 tablets. Participation eligibility. Participant eligibility includes age, gender, type and stage of ...
The purpose of this study is to investigate the safety and tolerability of two dose regimens of IFX-1 as add-on to standard of care (SOC) in subjects with ...
Histologically or cytologically confirmed recurrent solid tumors. 1. Cohort 1a: any extracranial solid tumor (may include EC, ovarian clear cell, or ovarian ...
The purpose of this registry is to use a comprehensive database to study syringomyelia and chiari 1 malformation, the natural history, and clinical course ...
Long-acting medicines are slowly released. So they last longer. Which one is best for you depends on your health and the condition being treated. Examples of ...
The purpose of this study is to evaluate molecular markers which might be a predictor of pancreatic cancer or precancer by analyzing the secretions (fluid) from ...
Human sympathetic neuronal discharge and recruitment ... discharge patterns in healthy humans. J ... 2017 Jul; 1 (1):100-110 Epub 2017 Apr 28. View ...
Mayo Clinic researchers have developed a genetic test that can help predict how people will respond to weight loss medications such as GLP-1s. ... November 1, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.